SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries informs about change in directorate

21 May 2021 Evaluate
Sun Pharmaceutical Industries has informed that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors, by way of circular resolutions passed on May 20, 2021, have approved the appointment of Pawan Goenka (DIN: 00254502), as an Additional Independent Director on the Board of the Company, with effect from May 21, 2021, to hold office upto the ensuing 29th Annual General Meeting of the Company; approved the appointment of Rama Bijapurkar (DIN: 00001835), as an Additional Independent Director on the Board of the Company, with effect from May 21, 2021 to hold office upto the ensuing 29th Annual General Meeting of the Company. The Company hereby confirmed that Pawan Goenka and Rama Bijapurkar are not related to any Director of the Company and are also not related to each other. It also confirmed that they both are not debarred from holding the office of Director by virtue of any order issued by the Securities and Exchange Board of India (SEBI) or any such other authority in accordance with the circular dated June 20, 2018, issued by the Stock Exchanges

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1668.00 -7.20 (-0.43%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×